Clinical trial
A Study Evulating DA-302168S Tablets in Overweight/Obese Subjects
NCT06541730
Study timeline
Study start (actual)2024-08-30Date precision: day
Registry last updated2025-04-16
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Overweight and Obesityunresolved
Interventions
DA-302168SDRUG
Sponsors & collaborators
Chendu DIAO Pharmaceutical Group CO., LTD.lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06541730 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.